7OQL
7OQL (compound 54) is a selective METTL3 inhibitor (IC50=0.054 µM) . 7OQL has the potential to be used in the study of cancer[1].
Product Specifications
UNSPSC
12352005
Target
METTL3
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/7oql.html
Solubility
10 mM in DMSO
Smiles
CC(C1N(CC12CCC2)CC3=CC4=C(C(NCC5(CCCN(C5)C6=NC=NC(NCC7=CC=CC=C7)=C6)O)=CC=C4)C=C3)C
Molecular Formula
C37H46N6O
Molecular Weight
590.80
References & Citations
[1]Rajiv Kumar Bedi, et al. Structure-Based Design of Inhibitors of the m6A-RNA Writer Enzyme METTL3. ACS Bio Med Chem Au. 2023 June 14.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6504655-01 0.1 mL
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (MaxLight 405)
Ask
View Details MBS6504655-02 5x 0.1 mL
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (MaxLight 405)
Ask
View Details